As of 2025-04-22, the EV/EBITDA ratio of Aspira Women's Health Inc (AWH) is -0.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AWH's latest enterprise value is 1.30 mil USD. AWH's TTM EBITDA according to its financial statements is -12.97 mil USD. Dividing these 2 quantities gives us the above AWH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 16.7x | 15.2x |
| Forward P/E multiples | 16.5x - 20.2x | 18.8x |
| Fair Price | (18.55) - (18.70) | (19.06) |
| Upside | -22716.7% - -22907.8% | -23344.7% |
| Date | EV/EBITDA |
| 2025-04-17 | -0.05 |
| 2025-04-16 | -0.10 |
| 2025-04-15 | -0.11 |
| 2025-04-14 | -0.11 |
| 2025-04-11 | -0.11 |
| 2025-04-10 | -0.11 |
| 2025-04-09 | -0.11 |
| 2025-04-08 | -0.11 |
| 2025-04-07 | -0.11 |
| 2025-04-04 | -0.11 |
| 2025-04-03 | -0.12 |
| 2025-04-02 | -0.12 |
| 2025-04-01 | -0.11 |
| 2025-03-31 | -0.11 |
| 2025-03-28 | -0.12 |
| 2025-03-27 | -0.13 |
| 2025-03-26 | -0.12 |
| 2025-03-25 | -0.11 |
| 2025-03-24 | -0.11 |
| 2025-03-21 | -0.11 |
| 2025-03-20 | -0.12 |
| 2025-03-19 | -0.13 |
| 2025-03-18 | -0.13 |
| 2025-03-17 | -0.14 |
| 2025-03-14 | -0.15 |
| 2025-03-13 | -0.16 |
| 2025-03-12 | -0.15 |
| 2025-03-11 | -0.18 |
| 2025-03-10 | -0.20 |
| 2025-03-07 | -0.19 |
| 2025-03-06 | -0.19 |
| 2025-03-05 | -0.18 |
| 2025-03-04 | -0.16 |
| 2025-03-03 | -0.17 |
| 2025-02-28 | -0.18 |
| 2025-02-27 | -0.18 |
| 2025-02-26 | -0.23 |
| 2025-02-25 | -0.22 |
| 2025-02-24 | -0.23 |
| 2025-02-21 | -0.22 |
| 2025-02-20 | -0.23 |
| 2025-02-19 | -0.24 |
| 2025-02-18 | -0.24 |
| 2025-02-14 | -0.24 |
| 2025-02-13 | -0.28 |
| 2025-02-12 | -0.30 |
| 2025-02-11 | -0.28 |
| 2025-02-10 | -0.34 |
| 2025-02-07 | -0.34 |
| 2025-02-06 | -0.37 |